Search for: "INVITROGEN V CLONTECH LABS"
Results 1 - 20
of 26
Sorted by Relevance
|
Sort by Date
25 Feb 2010, 7:34 am
The District of Delaware, following the Federal Circuit decision in Clontech Labs, Inc. v. [read post]
8 Jul 2010, 6:12 am
Del. 2010)] declined to draw an inference of deceptive intent from pleadings that the defendant knowingly marked certain articles with an expired patent number, this ruling departs from [Clontech Labs. [read post]
25 Mar 2013, 4:16 pm
”Invitrogen Corp. v. [read post]
4 Mar 2011, 2:48 am
The Court also held that the fact that RESTASIS was marked with an unexpired patent, did not insulate Allergan from marking with an expired patent as well, citing Clontech Labs., Inc. v. [read post]
15 Mar 2011, 10:50 am
As we explained in Clontech Labs, Inc. v. [read post]
6 Aug 2021, 2:53 pm
Clontech Labs., Inc., 429 F.3d 1052, 1064 (Fed. [read post]
6 Jan 2010, 7:33 pm
See Clontech Labs. [read post]
16 Mar 2011, 3:49 pm
See Clontech Labs., Inc. v. [read post]
13 Nov 2013, 8:40 pm
Clontech Labs., Inc., 429 F.3d 1052, 1063-64 (Fed. [read post]
28 Feb 2010, 5:10 pm
Clontech Labs. [read post]
10 Apr 2010, 9:11 am
Clontech Labs, Inc. v. [read post]
15 Jun 2010, 2:38 pm
” Pivotal to this aspect of false patent marking was the 2005 Federal Circuit case of Clontech Labs., Inc. v. [read post]
2 Dec 2011, 5:36 am
Clontech Labs., Inc., 429 F.3d 1052 (Fed. [read post]
21 Dec 2010, 10:07 am
Clontech Labs., Inc., 429 F.3d 1052, 1078 (Fed. [read post]
7 Sep 2012, 7:04 am
Clontech Labs., Inc., 429 F.3d 1052, 1080 (Fed. [read post]
29 Dec 2009, 6:46 pm
See Clontech Labs. [read post]
9 Aug 2013, 12:09 pm
Clontech Labs., Inc., 429 F.3d 1052, 1063 (Fed. [read post]
19 May 2011, 2:20 pm
Bon Tool, 590 F.3d 1295, 1304 (Fed.Cir.2009). (7) Clontech Labs. [read post]
4 Jan 2010, 2:37 pm
See Clontech Labs. [read post]
9 Aug 2010, 11:46 am
However, the government’s attorney contended that in view of past precedent such as Clontech Labs., Inc. v. [read post]
